Yang G - Search Results

1

Epigenetic and immunohistochemical characterization of the Clusterin gene in ovarian tumors.

Yang G, Zhang H, Liu Y, Zhou J, He W, Quick CM, Xie D, Smoller BR, Fan CY. Yang G, et al. Arch Gynecol Obstet. 2013 May;287(5):989-95. doi: 10.1007/s00404-012-2650-6. Epub 2012 Dec 4. Arch Gynecol Obstet. 2013. PMID: 23208459

2

Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.

Yang GF, Xie D, Liu JH, Luo JH, Li LJ, Hua WF, Wu HM, Kung HF, Zeng YX, Guan XY. Yang GF, et al. Gynecol Oncol. 2009 Feb;112(2):314-8. doi: 10.1016/j.ygyno.2008.10.024. Epub 2008 Dec 2. Gynecol Oncol. 2009. PMID: 19054548

3

Expression and clinical significance of YKL-40 protein in epithelial ovarian cancer tissues.

Yang GF, Cai PY, Li XM, Deng HX, He WP, Xie D. Yang GF, et al. Ai Zheng. 2009 Feb;28(2):142-5. Epub 2009 Feb 11. Ai Zheng. 2009. PMID: 19550125 Free article.

4

[Significance of expression of THY1 protein in epithelial ovarian cancer].

Yang GF, Chao K, Li XM, Rao HL, Deng HX, Wu HM, Xie D. Yang GF, et al. Zhonghua Zhong Liu Za Zhi. 2009 Mar;31(3):203-7. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19615261 Chinese.

5

Overexpression of clusterin in ovarian cancer is correlated with impaired survival.

Yang GF, Li XM, Xie D. Yang GF, et al. Int J Gynecol Cancer. 2009 Nov;19(8):1342-6. doi: 10.1111/IGC.0b013e3181a83ed9. Int J Gynecol Cancer. 2009. PMID: 20009887

6

Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma.

Cai MY, Zhang B, He WP, Yang GF, Rao HL, Rao ZY, Wu QL, Guan XY, Kung HF, Zeng YX, Xie D. Cai MY, et al. Cancer Sci. 2010 Jun;101(6):1543-9. doi: 10.1111/j.1349-7006.2010.01560.x. Epub 2010 Mar 10. Cancer Sci. 2010. PMID: 20367640 Free PMC article.

7

Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma.

Yang GF, He WP, Cai MY, He LR, Luo JH, Deng HX, Guan XY, Zeng MS, Zeng YX, Xie D. Yang GF, et al. BMC Cancer. 2010 Apr 8;10:133. doi: 10.1186/1471-2407-10-133. BMC Cancer. 2010. PMID: 20377880 Free PMC article.

8

EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.

Rao ZY, Cai MY, Yang GF, He LR, Mai SJ, Hua WF, Liao YJ, Deng HX, Chen YC, Guan XY, Zeng YX, Kung HF, Xie D. Rao ZY, et al. Carcinogenesis. 2010 Sep;31(9):1576-83. doi: 10.1093/carcin/bgq150. Epub 2010 Jul 28. Carcinogenesis. 2010. PMID: 20668008

9

Loss/Down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma.

Yang G, He W, Cai M, Luo F, Kung H, Guan X, Zeng Y, Xie D. Yang G, et al. Int J Gynecol Cancer. 2011 Apr;21(3):486-93. doi: 10.1097/IGC.0b013e31820fa168. Int J Gynecol Cancer. 2011. PMID: 21436696

10

CHD1L protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival.

He WP, Zhou J, Cai MY, Xiao XS, Liao YJ, Kung HF, Guan XY, Xie D, Yang GF. He WP, et al. BMC Cancer. 2012 Sep 29;12:437. doi: 10.1186/1471-2407-12-437. BMC Cancer. 2012. PMID: 23020525 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,199 results

Search Page

Filters